Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Provencher

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Survey of Ophthalmology|November 18, 2017
Glaucoma-associated corneal endothelial cell damage: A reviewBen J Janson, Wallace L Alward, Young H Kwon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterusPatricia Pautier, Eun Ji Nam, Diane M Provencher, et al.
Journal of Cataract and Refractive Surgery|June 24, 2022
Deadbolt cataract due to misplanted minishuntRichard D Ten Hulzen, Isabella V Wagner, Ahmad A Aref, et al.
Plos One|June 12, 2012
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosisCécile Le Page, Alexandre Marineau, Patrick K Bonza, et al.
American Journal of Obstetrics and Gynecology|July 1, 1990
Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistanceS C Rubin, C L Finstad, W J Hoskins, et al.
Oncogene|June 9, 2005
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profilingVéronique Ouellet, Diane M Provencher, Christine M Maugard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignanciesL H Lê, K D Swenerton, L Elit, et al.
Cancer Causes & Control : CCC|January 20, 2017
Hormonal and reproductive factors and the risk of ovarian cancerAnita Koushik, Anne Grundy, Michal Abrahamowicz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
BMC Cancer|May 30, 2008
Characterization of three new serous epithelial ovarian cancer cell linesVéronique Ouellet, Magdalena Zietarska, Lise Portelance, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Survey of Ophthalmology|November 18, 2017
Glaucoma-associated corneal endothelial cell damage: A reviewBen J Janson, Wallace L Alward, Young H Kwon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterusPatricia Pautier, Eun Ji Nam, Diane M Provencher, et al.
Journal of Cataract and Refractive Surgery|June 24, 2022
Deadbolt cataract due to misplanted minishuntRichard D Ten Hulzen, Isabella V Wagner, Ahmad A Aref, et al.
Plos One|June 12, 2012
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosisCécile Le Page, Alexandre Marineau, Patrick K Bonza, et al.
American Journal of Obstetrics and Gynecology|July 1, 1990
Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistanceS C Rubin, C L Finstad, W J Hoskins, et al.
Oncogene|June 9, 2005
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profilingVéronique Ouellet, Diane M Provencher, Christine M Maugard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignanciesL H Lê, K D Swenerton, L Elit, et al.
Cancer Causes & Control : CCC|January 20, 2017
Hormonal and reproductive factors and the risk of ovarian cancerAnita Koushik, Anne Grundy, Michal Abrahamowicz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
BMC Cancer|May 30, 2008
Characterization of three new serous epithelial ovarian cancer cell linesVéronique Ouellet, Magdalena Zietarska, Lise Portelance, et al.
Pageof 11